PharmaCyte Biotech (PMCB) 8-K Changes in Registrant's Certifying Accountant

Exhibit 16.1

ROBISON, HILL & CO.	Certified Public Accountants
A PROFESSIONAL CORPORATION
	DAVID O. SEAL, CPA
	W. DALE WESTENSKOW, CPA
	BARRY D. LOVELESS, CPA
	STEPHEN M. HALLEY, CPA

May 26, 2015

U.S. Securities and Exchange Commission

Office of the Chief Accountant

100 F Street NE

Washington, DC 20549

Re: PharmaCyte Biotech, Inc.

Ladies and Gentlemen:

We have read the statements under item 4.01 in the Form 8-K dated May 26, 2015, of PharmaCyte Biotech, Inc. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.

Very Truly Yours,

/s/ Robison, Hill & Co.

Certified Public Accountants

Salt Lake City, Utah

May 26, 2015